查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫療外骨骼市場-2022-2029
市場調查報告書
商品編碼
1140697

全球醫療外骨骼市場-2022-2029

Global Medical Exoskeleton Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期間（2022-2029 年），醫療外骨骼市場規模預計將以 48% 的複合年增長率增長。

外骨骼通過為肢體運動提供額外的力量來增加人類的體力。醫用外骨骼有助於改善身體殘疾者的生活質量，例如脊髓損傷、神經病、癱瘓和老年人。

市場動態

具有多自由度感官系統的低成本外骨骼機械手有望推動市場增長。

機器人技術和虛擬現實的快速發展需要更複雜的人機界面來實現高效的並行控制。外骨骼是一種可穿戴輔助技術，以高成本和大數據處理跟蹤多維人體運動。或者，用於定制外骨骼的通用且具有成本效益的解決方案以最小的功耗監測人體上肢的所有可移動關節是摩擦電雙向傳感器。它用於識別相應的運動，例如二自由度（DOF）肩部旋轉、手腕扭轉和彎曲運動，並實時控制虛擬角色和機械臂。隨後的運動分析從外骨骼和人體的結構完整性中提供了額外的物理參數，而無需引入其他傳感器。這種外骨骼型傳感系統作為一種低成本、高科技的人機界面具有很大的前景，用於在現實和虛擬世界中操縱物體，例如機器人自動化、醫療保健和培訓。因此，從上述描述來看，預計它將成為預測期內的市場驅動力。

限制

外骨骼的有限功率範圍、確保外骨骼獲得批准用於醫療應用的監管挑戰以及與醫療外骨骼相關的高成本預計將在預測期內阻礙市場。一些預期因素。例如，一個外骨骼的成本約為 45,000 美元，這是許多人買不起的。

行業分析

醫療外骨骼市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行深入分析。

COVID-19 影響分析

COVID-19 大流行對市場產生了積極影響。大流行給世界各地的醫療保健系統帶來了前所未有的壓力，包括護理的分配以及由於缺乏能力和資源，重症監護病房 (ICU) 無法安全地維持大量使用新興機械通氣的患者。嚴重影響臨床管理。已經發現從仰臥位到俯臥位（正面）的姿勢轉換（PP）可以增強需要機械通氣支持的急性呼吸窘迫綜合徵（ARDS）患者的氧合和通氣動力學。因此，PP 在 COVID-19 大流行期間被廣泛採用。例如，南希醫院 ICU 在前 10 天進行了 116 次 PP 手術，這與他們通常一年內進行的手術數量相當。使用外骨骼幫助醫護人員將機械通氣的 COVID-19 患者置於俯臥位。讓患者俯臥不是侵入性過程，但它是一項複雜的任務。

此外，人們越來越關注在工作場所人體工程學中使用外骨骼來減少體力工作量和患肌肉骨骼疾病的風險。外骨骼可以是主動的（電動的）或被動的，其中諸如彈簧之類的機械元件存儲和回收能量，將負載從身體的一個部位轉移到另一個部位。預計這將在預測期內提振醫療外骨骼市場。

細分分析

在醫療外骨骼市場中，預計被動外骨骼市場份額最大

2021 年，被動外骨骼市場份額最大。這部分受益，因為被動外骨骼通常比主動設備更便宜、更輕（例如，Collins 等人的腳踝外骨骼為 400 克，因此使其成為準被動（或半主動）設備）。結合動力和被動外骨骼特性在一個新的類別中可能會為外骨骼技術提供一個有前途的未來方向）。例如，EVO 是一種上半身提升外骨骼，旨在提高生產力和減少疲勞，並旨在消除頸部、肩部和背部的工作相關傷害。 EVO 基於業界首款工業背心 EksoVest，是世界上同類產品中最輕、最耐用、輔助性和自然順從性的工業外骨骼。此外，無源設備最多只能提供可在運動之間切換的固定機械特性，例如在軌道上跑步或以恆定速度下坡。因此，從上述描述來看，這種市場細分預計將在預測期內佔最大的市場份額。

區域分析

北美在全球醫用外骨骼市場佔有最大的市場份額

2021 年，北美市場份額最大。中風患病率上升、脊髓損傷 (SCI) 增加、老年人口增加、新產品發布和該地區主要市場參與者的批准是預計在預測期內推動市場發展的因素。任何運動都可能發生傷害，例如與其他運動員接觸造成的創傷，或過度使用或誤用身體部位。根據美國國家安全委員會 (NSC) 的數據，到 2020 年，騎自行車將造成近 426,000 人受傷，是所有體育和娛樂類別中最多的。有或沒有設備，運動其次是大約 378,000 例，其次是使用全地形車、輕便摩托車和小型自行車，大約 230,000 例，使用滑板、踏板車和氣墊板大約 218,000 例，我們排名第四。

此外，與游泳等非接觸性運動相比，人們越來越擔心足球等運動中的腦震盪風險。此外，美國食品藥品監督管理局（Food and Drug Administration）（ FDA ）於 2020 年批准了 501（k）許可，將 Ekso Bionics 的機器人外骨骼 EksoNR 商業化，用於獲得性腦損傷（ ABI ）患者。 EksoNR 是 FDA 批准的第一個用於 ABI 康復的外骨骼設備，將設備的範圍擴展到更廣泛的患者。因此，從上述陳述來看，預計北美地區將在預測期內佔據最大的市場份額。

競爭格局

醫療外骨骼市場的主要參與者是 Ekso Bionics Holdings, Inc.、ReWalk Robotics Ltd.、Exoskeleton Report LLC、Parker Hannifin Corp、CYBERDYNE Inc、Bionik Laboratories Corp、Gogoa Mobility Robots、Hocoma AG、Wearable Robotics SR、B -TEMIA Inc.等。這些公司在醫療外骨骼市場佔有很大份額。

這裡是 Hocoma AG。

概述

Hocoma 是開發、生產和營銷用於功能性運動治療的機器人和基於傳感器的設備的全球領導者。電氣和生物醫學工程師 Gery Colombo 和 Matthias Jorg 以及經濟學家 Peter Hostettler 於 1996 年作為有限責任公司創立了這家瑞士醫療技術公司。 Hocoma 與領先的診所和研究機構合作，創造尖端的治療解決方案。大約 160 名員工在蘇黎世附近的總部和美國、新加坡和斯洛文尼亞的子公司工作。我們擁有來自 25 個國家/地區的員工，是一家真正的全球化公司。瑞士 Hokoma 總部 35% 的員工是外國人，這增加了公司的多樣性。

產品組合

ArmeoPower：ArmeoPower 專為康復早期階段的手臂和手部治療而設計。該設備允許患有嚴重運動障礙的患者進行高度重複（高強度）的運動，這對於運動再學習最重要。

本報告提供 45 多個市場數據表、40 多個圖表和 180 頁有關全球醫療外骨骼市場的信息。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 第 3 章：按組件劃分的市場細分
  • 按類型劃分的市場細分
  • 按產品劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 配備多自由度感官系統的低成本外骨骼機械手有望推動市場增長。
    • 限制
      • 預計醫療外骨骼的高成本將阻礙市場增長。
    • 市場機會
    • 影響分析

第5章行業分析

  • 供應鏈分析
  • 定價分析
  • 法律法規分析
  • 未滿足的需求

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按組件

  • 硬件
    • 傳感器
    • 執行器
    • 控制系統
    • 電源
    • 其他
  • 軟件

第 8 章按類型

  • 動力外骨骼
  • 被動外骨骼

第 9 章按部分

  • 下半身外骨骼
  • 上身外骨骼

第 10 章按應用程序

  • 脊髓損傷
  • 創傷
  • 中風
  • 腦癱
  • 其他

第 11 章，最終用戶

  • 康復中心
  • 物理治療設施
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 13 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 14 章公司簡介

  • Ekso Bionics Holdings, Inc.
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • ReWalk Robotics Ltd.
  • Exoskeleton Report LLC
  • Parker Hannifin Corp
  • CYBERDYNE Inc.
  • Bionik Laboratories Corp
  • Gogoa Mobility Robots
  • Hocoma AG
  • Wearable Robotics SRL
  • B-TEMIA Inc（LIST NOT EXHAUSTIVE）

第15章 DataM

簡介目錄
Product Code: DMMD4650

Market Overview

Medical Exoskeleton Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 48% during the forecast period (2022-2029).

Exoskeletons are used to enhance a human's physical strength by offering additional strength to limb movements. Medical exoskeletons help physically challenged persons, such as spinal cord injuries, neurological disorders, paralysis, or aged persons to enhance their quality of life.

Market Dynamics

A low-cost exoskeleton manipulator with enhanced multiple degrees of freedom sensory system is expected to drive market growth.

Rapid advancements in robotics and virtual reality necessitate more complex human-machine interfaces to achieve efficient parallel control. The exoskeleton is a wearable assistive technology that tracks multi-dimensional human motions at a high cost and extensive data processing. Alternatively, a universal and cost-effective solution to a customized exoskeleton for monitoring all of the movable joints of the human upper limbs with minimal power consumption is a triboelectric bi-directional sensor. The corresponding movements, which include two degrees of freedom (DOF) shoulder rotations, wrist-twisting, and bending motions, are identified and used to control the virtual character and robotic arm in real-time. The subsequent kinetic analysis delivers additional physical parameters without introducing other sensors due to the structural consistency between the exoskeleton and the human body. This exoskeleton sensory system has a lot of promise as a low-cost, high-tech human-machine interface for manipulating objects in the real and virtual worlds, such as robotic automation, healthcare, and training. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Limited Power Range of exoskeleton, regulatory challenges for securing approvals for exoskeletons' medical applications, and the high cost associated with Medical Exoskeleton are some of the factors that the market is expected to get hampered in the forecast period. For instance, many people cannot afford an exoskeleton since they cost roughly $45,000.

Industry Analysis

The medical exoskeleton market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic had a positive impact on the market. The pandemic has put a strain on healthcare systems around the world like never before, with severe implications for clinical management, including rationing of care and the inability of Intensive Care Units (ICUs) to safely maintain a high number of patients on mechanical ventilation during the surge due to a lack of capacity and resources. Prone positioning (PP), or repositioning a patient from a supine to a prone position (i.e., on their front side), has been shown to enhance oxygenation and ventilatory mechanics in Acute Respiratory Distress Syndrome (ARDS) patients who require mechanical ventilatory assistance. As a result, during the COVID-19 pandemic, PP was widely employed. For instance, in the first ten days of the outbreak, the ICU at Nancy Hospital did 116 PP maneuvers, similar to the number of maneuvers they regularly perform in a year. Using exoskeletons to aid medical professionals during prone positioning of mechanically ventilated COVID-19 patients. Although putting a patient into the prone position is not an invasive process, it is complicated.

Moreover, there has been increasing interest in employing exoskeletons for workplace ergonomics to reduce physical workload and the risks of developing musculoskeletal disorders. Exoskeletons can be active (motorized) or passive, in which case mechanical elements such as springs store and restore energy, transferring the load from one body part to another. Thus, this is owing to boost the medical exoskeleton market in the forecast period.

Segment Analysis

Passive Exoskeleton segment is expected to hold the largest market share in medical exoskeleton market

The passive exoskeleton segment accounted for the largest market share in 2021. The segment is benefited because Passive exoskeletons are typically cheaper and lighter than active devices (e.g., Collins et al.'s ankle exoskeleton is 400 g, thereby, the combination of powered and passive exoskeleton characteristics in a new class of pseudo-passive (or semi-active) devices may provide a promising future direction for exoskeleton technology. For instance, EVO is an upper-body lifting exoskeleton designed to increase productivity and reduce fatigue, intending to eliminate work-related injuries to the neck, shoulder, and back. Building upon the industry's first industrial vest, EksoVest, EVO is the world's most lightweight, durable, assistive, and naturally-tracking industrial exoskeleton of its kind. Moreover, Passive devices can only offer fixed mechanical properties that are at best only switchable between locomotion bouts such as running on a track or hiking downhill at a fixed speed. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global medical exoskeleton market

North America accounted for the largest market share in 2021. The increasing prevalence of stroke, a growing number of spinal cord injuries (SCI), rising geriatric population, launches of new products, and approvals by leading market players in the region are some factors that the market is expected to boost the forecast period. For instance, injuries can occur in any sport, whether from the trauma of contact with other players or from overuse or misuse of a body part. According to the National Safety Council (NSC), in 2020, bicycling accounted for about 426,000 injuries, most of any sports and recreation category. With or without equipment, exercise followed with about 378,000 injuries, while ATV, moped and minibike use with 230,000 injuries, and skateboard, scooter and hoverboard use, with 218, 00 injuries, ranked third and fourth.

Moreover, the concern is growing about the risks of sports-related concussions such as football can be expected to result in a higher number of injuries than a noncontact sport such as swimming. Additionally, The US Food and Drug Administration (FDA) granted Ekso Bionics 501(k) permission in 2020 to commercialize their EksoNR robotic exoskeleton for patients with acquired brain damage (ABI). EksoNR is the first exoskeleton device to be cleared by the FDA for rehabilitation use with ABI, broadening the device's use to a far larger range of patients. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the medical exoskeleton market are Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Exoskeleton Report LLC, Parker Hannifin Corp, CYBERDYNE Inc., Bionik Laboratories Corp, Gogoa Mobility Robots, Hocoma AG, Wearable Robotics SR and B-TEMIA Inc.

Hocoma AG:

Overview:

Hocoma is the global industry leader in robotic and sensor-based devices for development, production, and marketing functional movement therapy. The electrical and biomedical engineers Gery Colombo and Matthias Jorg, as well as the economist Peter Hostettler, formed the Swiss medical technology firm in 1996 as a limited liability corporation. Hocoma creates cutting-edge therapy solutions in collaboration with top clinics and research institutions. Hocoma employs about 160 people at its headquarters near Zurich and its subsidiaries in the United States, Singapore, and Slovenia. They are a genuinely global organization, with employees from 25 different nations. 35 percent of the personnel at Hocoma's headquarters in Switzerland are international citizens, which adds to the company's diversity.

Product Portfolio:

ArmeoPower: The ArmeoPower has been specifically designed for arm and hand therapy in an early rehabilitation stage. The device enables even patients with severe movement impairments to perform exercises with high repetitions (high intensity), which is paramount for relearning motor function.

The global medical exoskeleton market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Component
  • 3.2. Market Snippet by Type
  • 3.3. Market Snippet by Extremity
  • 3.4. Market Snippet by Application
  • 3.5. Market Snippet by End User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. A low-cost exoskeleton manipulator with enhanced multiple degrees of freedom sensory system is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of medical exoskeleton are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component Segment
  • 7.2. Hardware*
    • 7.2.1. Sensor
    • 7.2.2. Actuator
    • 7.2.3. Control System
    • 7.2.4. Power Source
    • 7.2.5. Others
    • 7.2.6. Introduction
    • 7.2.7. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Software

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type Segment
  • 8.2. Powered Exoskeleton*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Passive Exoskeleton

9. By Extremity

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 9.1.2. Market Attractiveness Index, By Extremity Segment
  • 9.2. Lower Body Exoskeleton*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Upper Body Exoskeleton

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application Segment
  • 10.2. Spinal Cord Injury*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Trauma
  • 10.4. Stroke
  • 10.5. Cerebral Palsy
  • 10.6. Others

11. By End-user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Rehabilitation Centers*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 11.3. Physiotherapy Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Ekso Bionics Holdings, Inc.*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. ReWalk Robotics Ltd.
  • 14.3. Exoskeleton Report LLC
  • 14.4. Parker Hannifin Corp
  • 14.5. CYBERDYNE Inc.
  • 14.6. Bionik Laboratories Corp
  • 14.7. Gogoa Mobility Robots
  • 14.8. Hocoma AG
  • 14.9. Wearable Robotics SRL
  • 14.10. B-TEMIA Inc (*LIST NOT EXHAUSTIVE)

15. DataM Intelligence

  • 15.1. Appendix
  • 15.2. About Us and Applications
  • 15.3. Contact Us